Impact BioMedical, Inc. (IBO)
4.68
-0.16
(-3.31%)
USD |
NYAM |
Oct 06, 16:00
4.60
-0.08
(-1.71%)
After-Hours: 07:37
Impact BioMedical Total Liabilities (Quarterly) : 2.733M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.733M |
| March 31, 2026 | 2.375M |
| December 31, 2025 | 7.28M |
| September 30, 2025 | 27.06M |
| June 30, 2025 | 26.44M |
| March 31, 2025 | 13.24M |
| December 31, 2024 | 13.05M |
| September 30, 2024 | 12.34M |
| June 30, 2024 | 17.73M |
| March 31, 2024 | 17.09M |
| December 31, 2023 | 16.37M |
| September 30, 2023 | 15.50M |
| Date | Value |
|---|---|
| June 30, 2023 | 15.29M |
| March 31, 2023 | 14.48M |
| December 31, 2022 | 13.37M |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 16.50M |
| September 30, 2021 | |
| June 30, 2021 | 13.02M |
| March 31, 2021 | |
| December 31, 2020 | 6.320M |
| September 30, 2020 | 0.0798M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| LENZ Therapeutics, Inc. | 17.33M |
| Enveric Biosciences, Inc. | 0.8615M |
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
| Veru, Inc. | 8.651M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 16.74M |
| Shareholders Equity (Quarterly) | 10.77M |
| Current Ratio | 0.1565 |
| Net Debt Paydown Yield | 3.69% |